Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous

A pattern of use of stimulants including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones that has caused damage to a person’s physical or mental health or has resulted in behavior leading to harm to the health of others. The pattern of stimulant use is evident over a period of at least 12 months if substance use is episodic or at least one month if use is continuous (i.e., daily or almost daily). Harm to health of the individual occurs due to one or more of the following: (1) behavior related to intoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) a harmful route of administration. Harm to health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behavior related to stimulant intoxication on the part of the person to whom the diagnosis of Harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone applies.

Differential diagnosis

When diagnosing Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous, the following ICD-11 disorders should be considered in the differential diagnosis:

• Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0)
• Uzależnienie od środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.2)

Frequently asked questions

What disorders are in the differential diagnosis of Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous?

The differential diagnosis of Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous (6C46.11) includes: Epizod szkodliwego używania środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.0), Uzależnienie od środków pobudzających, w tym amfetaminy, metamfetaminy lub metylkatynonu (6C46.2).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C46.11 – WHO ICD-11